SANUWAVE Health Submits Final Module of PMA Application for FDA Approval of dermaPACE

SANUWAVE Health, Inc.

today announced that it has submitted to the U.S. Food and Drug Administration the third and final module of its Premarket Approval application for the dermaPACE device for the treatment of diabetic foot ulcers.